Researchers from USask have identified a potential target for eliminating breast cancer cells. The team was led by Dr. Franco ...

Women with advanced breast cancer who progress on prior CDK4/6 inhibition can still benefit from second-line treatment with a CDK4/6 inhibitor as part of combination therapy.

soton.ac.uk Background With significant developments in the management of metastatic breast cancer, the trajectory of progressive breast cancer is becoming increasingly complex with little ...